Long-term persistence of first-line biologics for psoriasis and psoriatic arthritis: A cohort study of 23,423 patients from the French health insurance database (SNDS)

被引：0
|
作者：
Vegas, Laura Pina [1 ,2 ]
Penso, Laetitia [1 ]
Claudepierre, Pascal [1 ,2 ]
机构：
[1] Univ Paris Est Creteil, Creteil, France
[2] Hop Henri Mondor, AP HP, Serv Rhumatol, Creteil, France
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
31764
引用
收藏
页码：AB78 / AB78
页数：1
相关论文
共 46 条
  • [31] Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health Records
    Jin, Yinzhu
    Landon, Joan E.
    Krueger, Whitney
    Liede, Alexander
    Desai, Rishi J.
    Kim, Seoyoung C.
    BIODRUGS, 2022, 36 (04) : 521 - 535
  • [32] Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health Records
    Yinzhu Jin
    Joan E. Landon
    Whitney Krueger
    Alexander Liede
    Rishi J. Desai
    Seoyoung C. Kim
    BioDrugs, 2022, 36 : 521 - 535
  • [33] Long-term improvements in physical function are associated with improvements in dactylitis, enthesitis, tender and swollen joint counts, and psoriasis skin involvement: Results from a phase 3 study of ustekinumab in psoriatic arthritis patients
    Gottlieb, Alice
    Puig, Lluis
    Kavanaugh, Arthur
    Ritchlin, Christopher
    Li, Shu
    You, Yin
    Mendelsohn, Alan M.
    Song, Michael
    Rahman, Proton
    McInnes, Iain B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB239 - AB239
  • [34] DESCRIPTIVE STUDY OF METASTATIC BREAST CANCER PATIENTS WITH LONG-TERM PROGRESSION-FREE SURVIVAL DURING FIRST-LINE HORMONE THERAPY: EXPERIENCE FROM A SINGLE CANCER CENTER
    Illarramendi, Jose Juan
    Salgado, Esteban
    Lainez, Nuria
    Vicente, Francisco
    Cordoba, Alicia
    Vera, Ruth
    BREAST, 2011, 20 : S42 - S43
  • [35] Long-term survival prediction in patients with acute brain lesions using ensemble machine learning algorithms: a cohort study with combined national health insurance service and its self-run hospital database
    Dougho Park
    Daeyoung Hong
    Suntak Jin
    Jong Hun Kim
    Hyoung Seop Kim
    Journal of Big Data, 12 (1)
  • [36] LONG-TERM SURVIVAL OUTCOME AND PROGNOSIS IN 2277 PATIENTS WITH CHRONIC MYELOID LEUKAEMIA ALLOCATED TO FIRST-LINE IMATINIB TREATMENT-NEW RESULTS FROM THE EUTOS IN-STUDY REGISTRY
    Pfirrmann, M.
    Saussele, S.
    Baccarani, M.
    Guilhot, J.
    Cervantes, F.
    Ossenkoppele, G.
    Lindoerfer, D.
    Hoffmann, V.
    Castagnetti, F.
    Hehlmann, R.
    Simonsson, B.
    HAEMATOLOGICA, 2013, 98 : 298 - 298
  • [37] Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study
    Jan A. Burger
    Paul M. Barr
    Tadeusz Robak
    Carolyn Owen
    Paolo Ghia
    Alessandra Tedeschi
    Osnat Bairey
    Peter Hillmen
    Steven E. Coutre
    Stephen Devereux
    Sebastian Grosicki
    Helen McCarthy
    David Simpson
    Fritz Offner
    Carol Moreno
    Sandra Dai
    Indu Lal
    James P. Dean
    Thomas J. Kipps
    Leukemia, 2020, 34 : 787 - 798
  • [38] Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study
    Burger, Jan A.
    Barr, Paul M.
    Robak, Tadeusz
    Owen, Carolyn
    Ghia, Paolo
    Tedeschi, Alessandra
    Bairey, Osnat
    Hillmen, Peter
    Coutre, Steven E.
    Devereux, Stephen
    Grosicki, Sebastian
    McCarthy, Helen
    Simpson, David
    Offner, Fritz
    Moreno, Carol
    Dai, Sandra
    Lal, Indu
    Dean, James P.
    Kipps, Thomas J.
    LEUKEMIA, 2020, 34 (03) : 787 - 798
  • [39] Long-term survival in patients with HER2-positive metastatic breast cancer treated with trastuzumab as first-line therapy: Seven-year follow-up of the French Observational Hermine Study
    Antoine, E.
    Dalenc, F.
    Hebert, C.
    Rivera, P.
    Romieu, G.
    Varoqueaux, N.
    Guastalla, J. P.
    Namer, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] First-line liposomal irinotecan+5 fluorouracil/leucovorin plus oxaliplatin in patients with pancreatic ductal adenocarcinoma: Long-term follow-up results from a phase 1/2 study
    Wainberg, Z.
    Bekaii-Saab, T.
    Boland, P.
    Dayyani, F.
    Macarulla, T.
    Mody, K.
    Belanger, B.
    Maxwell, F.
    Moore, Y.
    Thiagalingam, A.
    Wang, T.
    Zhang, B.
    Dean, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S241 - S241
12345